Form 4: Fulgent Genetics CEO Sells Shares for Tax Obligations

Fulgent Genetics CEO Ming Hsieh disposed of 2,115 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Ming Hsieh, the Chief Executive Officer, Director, and a 10% Owner of Fulgent Genetics, Inc. (FLGT), reported a transaction on August 23, 2025.
• The transaction involved the disposition of 2,115 shares of Fulgent Genetics common stock at a price of $21.77 per share.
• This disposition was made to satisfy tax withholding obligations that arose upon the vesting of restricted stock units (RSUs) granted to Mr. Hsieh on February 23, 2023.
• Following this transaction, Mr. Hsieh directly beneficially owns 807,225 shares of common stock.
• Indirect beneficial ownership includes 7,895,115 shares held by the Dynasty Trust, 220,816 shares held by The Ming Hsieh Trust, and 2,000 shares held across two Uniform Transfer to Minor Accounts.

Sentiment

Score: 5

Explanation: Neutral. The transaction is a routine tax-related disposition of shares upon RSU vesting, not indicative of a change in management's view on the company's prospects or any fundamental shift in the company's performance.

Positives

• The transaction represents the vesting of previously granted restricted stock units, indicating a form of executive compensation being realized.
• The disposition was for tax withholding purposes, which is a non-discretionary event and not indicative of a change in management's sentiment towards the company's future.

Negatives

• A reduction in the direct beneficial ownership of common stock by a key executive, although for a routine tax-related reason.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is a common occurrence across all industries and does not provide specific insights into broader industry trends or competitive landscape.

Comparison to Industry Standards

• Tax-related dispositions of shares upon the vesting of restricted stock units are a standard practice for executives across publicly traded companies to manage their tax liabilities, aligning with common compensation and tax planning strategies in the industry.

Related Party Transactions

• The filing details indirect beneficial ownership through the Dynasty Trust, where Mr. Hsieh is the grantor and serves on the investment committee, and The Ming Hsieh Trust, where Mr. Hsieh is the trustee with sole voting and dispositive power.
• Shares are also held in Uniform Transfers to Minor Act accounts for which Mr. Hsieh acts as custodian and possesses sole voting and dispositive power.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine tax-related transaction for executive compensation and does not signal a change in company fundamentals or management's long-term commitment.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations upon RSU vesting. It does not reflect a change in the executive's investment thesis or the company's fundamentals. Therefore, it provides no new information to warrant a change in investment recommendation.

Keywords

Fulgent Genetics, FLGT, Ming Hsieh, CEO, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Beneficial Ownership